Ocular Therapeutix, Inc. (OCUL)
14.65
-0.76
(-4.93%)
USD |
NASDAQ |
Dec 11, 16:00
14.51
-0.14
(-0.96%)
After-Hours: 20:00
Ocular Therapeutix Market Cap: 3.121B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 54.55B |
| Hologic, Inc. | 16.68B |
| Vertex Pharmaceuticals, Inc. | 113.16B |
| Bristol Myers Squibb Co. | 104.22B |
| Krystal Biotech, Inc. | 7.151B |
Market Cap Related Metrics
| PS Ratio | 45.56 |
| PEG Ratio | -1.154 |
| Price to Book Value | 12.09 |
| Price | 14.65 |
| Earnings Yield | -9.80% |
| PEGY Ratio | -1.154 |